What did the FDA committee members decide
The intensity of nausea typically correlates with dose escalation and tends to be most pronounced during the first few weeks of treatment or following dose increases
L-carnitina e sovrappeso Proprio in virt del ruolo di trasportatore mitocondriale di acidi grassi a lunga catena, alla Carnitina sono state da sempre attribuite attivit lipolitiche, potenzialmente utili nella lotta all'obesit
Novo Nordisk has filed for a label expansion in the United States and expects a decision in the first half of 2025.
Key signs include: Persistent, severe abdominal pain that often radiates to the back Nausea and vomiting, which may accompany or follow the pain Abdominal tenderness, sometimes with a swollen or distended abdomen Fever and an elevated heart rate, which indicate inflammation or infection Risk Reduction Strategies For those using Mounjaro, taking proactive steps can help minimise risks: Before starting Mounjaro, discuss your medical history, particularly if you have a history of pancreatitis, gallstones, or other pancreatic conditions with a healthcare professional or book a consultation with us to discuss your suitability